imatinib mesylate has been researched along with Gallbladder Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diaz-Perez, JA; Mastrodimos, M; Reddy, A | 1 |
| Kluge, R; Mössner, J; Roth, A; Schleyer, E; Schoppmeyer, K; Wiedmann, M; Wittekind, C | 1 |
1 trial(s) available for imatinib mesylate and Gallbladder Neoplasms
| Article | Year |
|---|---|
Imatinib mesylate for palliative second-line treatment of advanced biliary tract cancer: a bicentric phase II study.
Topics: Aged; Antineoplastic Agents; Benzamides; Bile Duct Neoplasms; Cholangiocarcinoma; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Gallbladder Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasm Staging; Palliative Care; Piperazines; Prospective Studies; Pyrimidines | 2011 |
1 other study(ies) available for imatinib mesylate and Gallbladder Neoplasms
| Article | Year |
|---|---|
Gastrointestinal stromal tumor with synchronous gallbladder adenocarcinoma.
Topics: Adenocarcinoma; Aged; Anastomosis, Surgical; Antigens, Neoplasm; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Cholecystectomy; Combined Modality Therapy; Female; Gallbladder Neoplasms; Gastritis; Gastrointestinal Stromal Tumors; Helicobacter Infections; Helicobacter pylori; Humans; Ileal Neoplasms; Imatinib Mesylate; Laparotomy; Neoplasms, Multiple Primary; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrimidines | 2014 |